Prof. Eric Rush

Go Back

Clinical Geneticist

  • Children’s Mercy, Kansas City, MO
  • location United States
Prof. Eric Rush has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Alexion, AstraZeneca Rare Disease, Ultragenyx, BioMarin, Inozyme, Ipsen, Aruvant, Ascendis, Intercept, Spectrum

Programmes developed by Prof. Eric Rush

Podcast

Episode

3

of 3

episode
Bone diseases 
ASBMR 2022 Rare Bone Disease Highlights

Episode 3: Patient Advocate Perspective

Experts
Prof. Eric Rush, Ms. Inês Alves, Ms. Tracy Hart
  • download Downloadable
    Resources
  • clock 23 MIN
  • calendar Sep 2022

This educational programme is supported by an Independent Medical Education Grant from Ipsen
Podcast

Episode

2

of 3

episode
Bone diseases 
ASBMR 2022 Rare Bone Disease Highlights

Episode 2: Clinician Perspective

Experts
Prof. Eric Rush, Ms. Inês Alves, Ms. Tracy Hart
  • download Downloadable
    Resources
  • clock 16 MIN
  • calendar Sep 2022

This educational programme is supported by an Independent Medical Education Grant from Ipsen
Rare bone disease e-learning Interactive e-learning
Rare diseases Pediatrics Bone diseases 
Rare bone disease e-learning

Experts
Assoc. Prof. Marelise Eekhoff, Prof. Dr Oliver Semler, Prof. Eric Rush, Dr Kassim Javaid, Ms. Charlene Waldman, Ms. Inês Alves, Dr Zulf Mughal
  • download Downloadable
    Resources
  • clock 60 MIN
  • calendar Nov 2021

This educational programme is supported by an Independent Medical Education Grant from Ipsen, Kyowa Kirin and Ultragenyx
Episode 4: ASBMR 2021 Rare Bone Disease Highlights (full meeting coverage) Podcast

Episode

4

of 4

episode
Bone diseases Rare diseases 
ASBMR 2021 Rare Bone Disease Highlights

Episode 4: Full Meeting Coverage

Experts
Prof. Eric Rush, Assoc. Prof. Marelise Eekhoff
  • download Downloadable
    Resources
  • clock 15 MIN
  • calendar Oct 2021

This educational programme is supported by an Independent Medical Education Grant from Ipsen, Kyowa Kirin and Ultragenyx